Join us for the upcoming – DaRe2THINK Webinar

This talk is part of a series hosted by the DaRe2THINK trial to provide information to allied healthcare professionals and general practice staff across the UK.

This talk provides a practical update on how wearable devices detect atrial fibrillation (AF), and how to interpret alerts in a clinical context. It offers information on what steps to take when a patient presents with a watch/device-detected AF episode, in the context of the 2024 ESC Guidelines on AF.

Speaker: Dr Emma Svennberg

Dr. Emma Svennberg is an Assistant Professor, Electrophysiologist, and Head of Specialty Training at the Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden. Her primary research interests focus on atrial fibrillation (AF) screening, particularly systematic approaches, where she has played a key role in the large population-based screening studies STROKESTOP I & II. 

Dr. Svennberg has been recognized with the Swedish Society of Cardiology Research Award twice and holds fellowships with the European Society of Cardiology (ESC) and the European Heart Rhythm Association (EHRA). She was a founding member and later President of the Swedish branch of Cardiologists of Tomorrow. In 2024, she was elected Treasurer of the EHRA board and currently serves on its Executive Board. She was also part of the ESC 2024 Task Force for the Atrial Fibrillation Guidelines.

DaRe2THINK

This webinar is hosted by DaRe2THINK, a primary care clinical trial sponsored by the NIHR, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust.

DaRe2THINK is a transformational project that will test a new way of running clinical trials at General Practices in the NHS. The trial will use health information already collected in the NHS to reduce the time taken for research, both for the patients and NHS staff. This will allow the NHS to reach new and larger groups of patients that could benefit from new treatments opening the possibility of research to populations that would not have previously taken part.

Webinar schedule:

12:00 – 12:15 – Presentation by Dr Emma Svennberg

12:15 – 12:25 – Q&A and discussion

12:25 – 12:30 – The DaRe2THINK trial

Key benefits:

• Continuing Professional Development
• Learn from academic healthcare professionals (HCPs)
• Be informed of relevant published findings
• Engage in discussions with other HCPs
• Exclusive insight into an ongoing national trial
• Find out how to get involved yourself!